FHIT and neoplasm: FHIT acts as a tumor suppressor and is localized in the chromosomal region 3p14.2, close to the most common fragile site of the human genome FRA3B; loss of function of the FHIT protein is associated with increased proliferation and reduction in the apoptosis index and is an independent indicator of clinical outcome [110,111,112,113,114].